Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current practice and physicians' opinion about preoperative hair removal as a part of ERAS pathway implementation in gynecology and gynecology-oncology: a NOGGO-AGO survey of 148 gynecological departments in Germany.
Plett H, Ricciardi E, Bommert M, Veldink H, Traut A, Pietzner K, Zelal Muallem M, Sehouli J. Plett H, et al. Arch Gynecol Obstet. 2019 Jun;299(6):1607-1618. doi: 10.1007/s00404-019-05132-w. Epub 2019 Apr 5. Arch Gynecol Obstet. 2019. PMID: 30953189
Dataset on patients with Recurrent Borderline Ovarian Tumors and Table with Review of Literature on Fertility and Oncologic Outcomes of patients with Borderline Ovarian Tumors.
Plett H, Ricciardi E, Harter P, Ataseven B, Heitz F, Prader S, Schneider S, Heikaus S, Fisseler-Eckhoff A, Kommoss F, Lax SF, Staebler A, Traut A, du Bois A. Plett H, et al. Data Brief. 2020 Apr 30;30:105653. doi: 10.1016/j.dib.2020.105653. eCollection 2020 Jun. Data Brief. 2020. PMID: 32395597 Free PMC article.
Prevalence of BRCA1 and BRCA2 Mutations in Patients with Primary Ovarian Cancer - Does the German Checklist for Detecting the Risk of Hereditary Breast and Ovarian Cancer Adequately Depict the Need for Consultation?
Ataseven B, Tripon D, Rhiem K, Harter P, Schneider S, Heitz F, Baert T, Traut A, Pauly N, Ehmann S, Plett H, Schmutzler RK, du Bois A. Ataseven B, et al. Among authors: plett h. Geburtshilfe Frauenheilkd. 2020 Sep;80(9):932-940. doi: 10.1055/a-1222-0042. Epub 2020 Sep 2. Geburtshilfe Frauenheilkd. 2020. PMID: 32905297 Free PMC article.
Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter study.
Plett H, Filippova OT, Garbi A, Kommoss S, Rosendahl M, Langstraat C, Phadnis S, Muallem MZ, Baert T, Chi DS, Aletti GD, Taran FA, Ramspott JP, Zivanovic O, du Bois A, Sonoda Y, Gardner G, Traut A, Roche KL, Harter P. Plett H, et al. Gynecol Oncol. 2020 Nov;159(2):434-441. doi: 10.1016/j.ygyno.2020.08.028. Epub 2020 Sep 9. Gynecol Oncol. 2020. PMID: 32919778 Free PMC article.
Response evaluation after neoadjuvant therapy: evaluation of chemotherapy response score and serological and/or radiological assessment of response in ovarian cancer patients.
Ramspott JP, Baert T, MacKintosh ML, Traut A, Ataseven B, Bommert M, Heitz F, Plett H, Schneider S, Waltering KU, Heikaus S, Harter P, du Bois A. Ramspott JP, et al. Among authors: plett h. Arch Gynecol Obstet. 2021 Oct;304(4):1021-1032. doi: 10.1007/s00404-021-06020-y. Epub 2021 Mar 4. Arch Gynecol Obstet. 2021. PMID: 33661392
Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence.
Plett H, Ricciardi E, Vacaru V, Ramspott JP, Colombo N, Sehouli J, du Bois A, Garbi A, Richter R, Ataseven B, Aletti G, Braicu E, Heitz F, Portuesi R, Muallem MZ, Dagres T, Parma G, Roser E, Traut A, Multinu F, Harter P. Plett H, et al. Int J Gynecol Cancer. 2023 May 1;33(5):734-740. doi: 10.1136/ijgc-2022-003854. Int J Gynecol Cancer. 2023. PMID: 36759002
21 results